Clinical Trial Update: Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluates the combination of pembrolizumab with trifluridine/tipiracil in patients with previously treated advanced gastric cancer and gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Yonsei University | Conditions: Gastric and Gastroesophageal Junction Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING